Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 19.817B	--
--	2024/Q4	-- / 19.766B	--
Oct 29, 2024	2024/Q3	18.680B / 18.864B	--
Aug 29, 2024	2024/Q2	18.695B / 21.205B	--
--	2024/Q1	19.090B / 19.860B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 19.817B--

--2024/Q4-- / 19.766B--

Oct 29, 20242024/Q318.680B / 18.864B--

Aug 29, 20242024/Q218.695B / 21.205B--

--2024/Q119.090B / 19.860B--

Unlock Free Earnings Estimates

Open Account

China National Accord Medicines Corporation Earnings Reports

Sinopharm is consistent: 2024 performance forecast

Jan 17 11:00 ET

Sinopharm is consistent: report for the third quarter of 2024

Oct 28, 2024 12:00 ET

Sinopharm is consistent: quick performance report for the first three quarters of 2024

Oct 22, 2024 12:00 ET

Sinopharm is consistent: summary of the 2024 semi-annual report

Aug 28, 2024 12:00 ET

Symbol Price % Chg

Anhui Bossco Environmental Protection Technology

300422

5.32 +20.09%

MH Robot & Automation

301199

35.99 +20.01%

Shanghai Hajime Advanced Material Technology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 21, 2025

Strong Buy

Strong Buy
90.00%
Buy
10.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Shenzhen Special Zone

Intraday+0.89%

Monoclonal Antibody Concept

Intraday+0.53%

Shenzhen Stock Exchange

Intraday+0.28%